Stay updated on NanoFlu Vaccine Safety & Immunogenicity Clinical Trial
Sign up to get notified when there's something new on the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page.

Latest updates to the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedSite updates include adding Revision: v3.4.2 and removing older notices such as the funding/operating status message and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice informing users that information may not be up to date and guiding them to cc.nih.gov and opm.gov; updated the revision to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now includes a glossary toggle and updates the footer metadata to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'; previously it displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 has been added in place of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section has been added, featuring North Carolina sites (Raleigh, Rocky Mount, Statesville) and the page revision updated to v3.3.3; the previous North Carolina Locations heading and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to NanoFlu Vaccine Safety & Immunogenicity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page.